Adjuvant chemotherapy for breast cancer: who needs it?
Proton beam therapy in the UK: usage and monitoring
The evolution of BTOG and thoracic oncology care in the UK
Targetable immune checkpoint molecules in lung cancer
Joseph Paul Eder
Toxicity: immunotherapy vs chemotherapy